Misnomers in Dermatology

Barankin, Benjamin; Freiman, Anatoli

doi:10.1007/s10227-005-0102-7

Cited by 6 publications

(6 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2,19 Further support for the term PG stems from the understanding that the dermatosis is not related to or associated with any active or previous herpes infection. 25…”

Section: Pemphigoid Gestationismentioning

confidence: 99%

Dermatoses of pregnancy: Nomenclature, misnomers, and myths

Danesh

Pomeranz

McMeniman

et al. 2016

Clinics in Dermatology

View full text Add to dashboard Cite

The most recent reclassification of dermatoses of pregnancy includes polymorphic eruption of pregnancy, atopic eruption of pregnancy, and pemphigoid gestationis; intrahepatic cholestasis of pregnancy, strictly not a dermatosis, was included in specific dermatoses of pregnancy for working purposes. Another dermatosis, pustular psoriasis of pregnancy, could be included for similar reasons. The nomenclature of these pregnancy-specific eruptions has been revised several times, generating potential confusion among practitioners. Clouding the picture further are misnomers that have been used to describe dermatoses of pregnancy. In addition, several cutaneous conditions that are associated with, but not specific to, pregnancy, have been misunderstood, which has resulted in certain myths among patients and physicians. In this contribution, we describe how the nomenclature of each dermatosis of pregnancy has evolved to fit the current classification scheme. We then identify several misnomers that have generated confusion within the scheme. Finally, we debunk several myths that have developed around cutaneous conditions outside of this scheme, in both mother and newborn.

show abstract

“…2,19 Further support for the term PG stems from the understanding that the dermatosis is not related to or associated with any active or previous herpes infection. 25…”

Section: Pemphigoid Gestationismentioning

confidence: 99%

Dermatoses of pregnancy: Nomenclature, misnomers, and myths

Danesh

Pomeranz

McMeniman

et al. 2016

Clinics in Dermatology

View full text Add to dashboard Cite

show abstract

“…The term “collagen disorders” should be restricted to inherited conditions that affect the synthesis or expression of collagen, such as Ehlers–Danlos syndrome and osteogenesis imperfecta. [ 16 ]…”

Section: Introductionmentioning

confidence: 99%

“…The lesion is not purulent and pustules, if present, represent secondary infection due to streptococci or staphylococci. [ 16 ]…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Misnomers in dermatology: An update

2013

View full text Add to dashboard Cite

The name of a condition in dermatology, gives a clue regarding the clinical feature, etiology, or histopathology of the disease. A disease might have been termed wrongly due to its resemblance to another known condition. Misnomers often mislead a physician regarding the etiology or histopathology of the condition. Here is a list of misnomers, with explanation, and the appropriate name in parentheses.

show abstract

“…However, the designation is a misnomer since no association with a fungus exists. 2 The choice of the best treatment modality largely depends on the clinical staging of MF, which is depicted in Table 1. 3 The concept of ''stage-directed therapy'' guides therapeutic choices, and the management modalities can be divided into (1) skin-directed therapies, which are primarily effective in early disease, and (2) systemic therapies, used in advanced cases.…”

mentioning

confidence: 99%

Treatment of Mycosis Fungoides: Overview

Freiman

Sasseville

2006

J Cutan Med Surg

Self Cite

View full text Add to dashboard Cite

Skin-directed MF therapies include topical corticosteroids, nitrogen mustard, carmustine (BCNU), topical bexarotene gel, imiquimod cream, radiotherapy, total skin electron beam therapy, and phototherapy. Systemic therapies include extracorporeal photopheresis, interferon, oral bexarotene, denileukin diftitox, monoclonal antibodies and cytokine therapy, and other systemic chemotherapy. Finally, some investigative therapeutic modalities are presented.

show abstract

Misnomers in Dermatology

Cited by 6 publications

References 34 publications

Dermatoses of pregnancy: Nomenclature, misnomers, and myths

Dermatoses of pregnancy: Nomenclature, misnomers, and myths

Misnomers in dermatology: An update

Treatment of Mycosis Fungoides: Overview

Contact Info

Product

Resources

About